FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
RSV vaccine acceptance grows amidst rising flu concerns - News-Medical.net
3 days ago · Over half of U.S. adults (52%) think the vaccine given to pregnant individuals to protect their infants from RSV (respiratory syncytial virus) is effective, up from 42% in October 2023, soon after ...
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
CDC Revises RSV Vaccine Guidelines Over Side Effect Concerns - WebMD
Aug. 7, 2024 – The CDC has published updated recommendations for older adults, detailing who should get vaccinated against respiratory syncytial virus (RSV).
Respiratory syncytial virus | AP News - Associated Press News
U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns. The respiratory infection fills hospitals with wheezing babies every fall and winter.
FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV …
Today, the U.S. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory...
Progress at last against RSV - Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has...
RSVpreF vaccine found effective in preventing severe RSV in older …
Dec 18, 2024 · Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according to a study ...
‘A good day’: FDA approves world’s first RSV vaccine - Nature
May 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first RSV vaccine to gain...
RSV: Jab for winter virus could cut baby hospitalisations by 80
Dec 27, 2023 · Hospital admissions from a winter virus could be reduced by more than 80% if babies are given a single dose of a new antibody treatment, a study says. Respiratory syncytial virus (RSV) usually...